Consolidation, maintenance and continuous therapy for multiple myeloma in the era of novel agents
10.3760/cma.j.issn.1006-9801.2016.08.017
- VernacularTitle:新药时代多发性骨髓瘤的巩固、维持和持续治疗
- Author:
Wanqiu ZHU
- Publication Type:Journal Article
- Keywords:
Multiple myeloma;
Consolidation therapy;
Maintenance therapy;
Continuous therapy
- From:
Cancer Research and Clinic
2016;28(8):561-565
- CountryChina
- Language:Chinese
-
Abstract:
With the application of novel agents and high-dose chemotherapy with autologous stem cell transplantation(ASCT),the survival time of multiple myeloma(MM) has been significantly prolonged.However,due to the biological characteristics of myeloma and minimal residual disease after initial treatment,the disease courses of most MM patients show a series of remissions and relapses.Hence,it is necessary to apply consolidation and maintenance therapy after ASCT and continuous therapy for transplant-ineligible patients.This paper reviews the advances in consolidation,maintenance and continuous therapy for MM in the era of novel agents.
